New evidence for a blood-based biomarker for Alzheimer's disease

by Massachusetts General HospitalCredit: CC0 Public DomainA potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new resear

Updated on: April 10,2024

New evidence for a blood-based biomarker for Alzheimer's disease

by Massachusetts General HospitalCredit: CC0 Public DomainA potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new resear

Updated on:April 10,2024

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Updated on: April 01,2024

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Updated on:April 01,2024

Breathing coordinates brain rhythms for memory consolidation during sleep

Breathing coordinates brain rhythms for memory consolidation during sleepbyNorthwestern UniversityCorresponding author Andrew Sheriff looks at a computer monitor in a lab. Credit: Northwestern U

Updated on: January 15,2025

Breathing coordinates brain rhythms for memory consolidation during sleep

Breathing coordinates brain rhythms for memory consolidation during sleepbyNorthwestern UniversityCorresponding author Andrew Sheriff looks at a computer monitor in a lab. Credit: Northwestern U

Updated on:January 15,2025

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

Inflammatory dietary habits linked to 84% higher risk of dementia

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, Boston University School of Medi

Updated on: February 02,2025

Inflammatory dietary habits linked to 84% higher risk of dementia

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, Boston University School of Medi

Updated on:February 02,2025

Research reveals possible link between gastrointestinal syndromes and risk of brain aneurysm

by Society of NeuroInterventional SurgeryCredit: Pixabay/CC0 Public DomainThere is a potential connection between a diagnosis of certain gastrointestinal (GI) syndromes and the formation and rupture o

Updated on: July 31,2024

Research reveals possible link between gastrointestinal syndromes and risk of brain aneurysm

by Society of NeuroInterventional SurgeryCredit: Pixabay/CC0 Public DomainThere is a potential connection between a diagnosis of certain gastrointestinal (GI) syndromes and the formation and rupture o

Updated on:July 31,2024

Identification of a central regulator

by Ludwig Maximilian University of MunichC1q (green) and ApoE (red) proteins form deposits in the choroid plexus, as the researchers revealed by super-resolution microscopy. Bar 1 µm. Credit: C.

Updated on: March 09,2024

Identification of a central regulator

by Ludwig Maximilian University of MunichC1q (green) and ApoE (red) proteins form deposits in the choroid plexus, as the researchers revealed by super-resolution microscopy. Bar 1 µm. Credit: C.

Updated on:March 09,2024

A new biomarker of brain inflammation in early-stage Alzheimer's disease

by European Molecular Biology OrganizationResearchers at the Ludwig-Maximilians-University, the German Center for Neurodegenerative Diseases (DZNE), and the Institute for Stroke and Dementia Rese

Updated on: February 28,2024

A new biomarker of brain inflammation in early-stage Alzheimer's disease

by European Molecular Biology OrganizationResearchers at the Ludwig-Maximilians-University, the German Center for Neurodegenerative Diseases (DZNE), and the Institute for Stroke and Dementia Rese

Updated on:February 28,2024

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024

Can having a stroke change your sleep?

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainPeople who have had a stroke may be more likely to sleep too much or too little compared to those without prior stroke, according

Updated on: September 23,2024

Can having a stroke change your sleep?

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainPeople who have had a stroke may be more likely to sleep too much or too little compared to those without prior stroke, according

Updated on:September 23,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

by Institut de Recerca Sant Pau (Sant Pau Research Institute)(A) Map of Spain and its regions. (B) Map of La Rioja province and its regions. Regions belonging to the south-eastern area of La Rioja, wh

Updated on: July 17,2024

Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

by Institut de Recerca Sant Pau (Sant Pau Research Institute)(A) Map of Spain and its regions. (B) Map of La Rioja province and its regions. Regions belonging to the south-eastern area of La Rioja, wh

Updated on:July 17,2024